| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/1999 | CA2294764A1 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | CA2294746A1 New compounds |
| 01/14/1999 | CA2294734A1 Compounds |
| 01/14/1999 | CA2294530A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | CA2294117A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | CA2294046A1 Glucagon antagonists/inverse agonists |
| 01/14/1999 | CA2293501A1 Nitric oxide-releasing amidine-derived diazeniumdiolates, compositions and uses thereof |
| 01/14/1999 | CA2293324A1 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 01/14/1999 | CA2291758A1 2-substituted 4,5-diaryl imidazoles |
| 01/14/1999 | CA2290509A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | CA2288852A1 Antiallergic agents |
| 01/14/1999 | CA2285479A1 (s) 2-methylamino-2-phenyl-n-butyl 3,4,5-trimethoxybenzoate, its application to the treatment of chronic pain |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase |
| 01/13/1999 | EP0890571A1 Process for the preparation of(1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate |
| 01/13/1999 | EP0890362A1 Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy |
| 01/13/1999 | EP0890359A1 Tablets containing beta-lactam antibiotic and process for producing the same |
| 01/13/1999 | EP0890105A1 Methods for diagnosing and treating alzheimer's disease |
| 01/13/1999 | EP0890101A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 01/13/1999 | EP0889972A1 Diagnostic method and apparatus |
| 01/13/1999 | EP0889969A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/13/1999 | EP0889907A1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 01/13/1999 | EP0889906A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 01/13/1999 | EP0889905A1 Cytokine antagonists and agonists |
| 01/13/1999 | EP0889902A1 Antibiotic peptides from bovine milk |
| 01/13/1999 | EP0889901A1 Process and intermediates for the synthesis of lhrh antagonists |
| 01/13/1999 | EP0889900A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 01/13/1999 | EP0889898A1 Morpholinyl anthracycline derivatives |
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 01/13/1999 | EP0889893A1 Azaspiroderivatives |
| 01/13/1999 | EP0889892A1 Azaspiro derivatives |
| 01/13/1999 | EP0889891A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 01/13/1999 | EP0889889A1 Piperazine and piperidine compounds |
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889887A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889886A1 Novel phenanthridines substituted in the 6 position |
| 01/13/1999 | EP0889884A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation |
| 01/13/1999 | EP0889881A1 New triazoles as therapeutic agents for fungal infections |
| 01/13/1999 | EP0889880A1 Eprosartan dihydrate and a process for its production and formulation |
| 01/13/1999 | EP0889878A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
| 01/13/1999 | EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 01/13/1999 | EP0889876A1 Meta-substituted phenylene sulphonamide derivatives |
| 01/13/1999 | EP0889875A1 Cyclopropyl alkanoic acid derivatives |
| 01/13/1999 | EP0889737A1 Obesity protein compounds and formulations thereof |
| 01/13/1999 | EP0889734A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof |
| 01/13/1999 | EP0889732A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/13/1999 | EP0889728A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/13/1999 | EP0889727A1 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles |
| 01/13/1999 | EP0889725A1 Method for treating bipolar disorder |
| 01/13/1999 | EP0889724A1 Cox-2 selective inhibitors for managing labour and uterine contractions |
| 01/13/1999 | EP0889690A1 Antibiotic cocktail and method of use |
| 01/13/1999 | EP0804202A4 Estrogens and parathyroid hormone for treating osteoporosis |
| 01/13/1999 | EP0789567A4 A method for treating vascular headaches |
| 01/13/1999 | EP0757670B1 Benzamide derivatives as vasopressin antagonists |
| 01/13/1999 | EP0731787B1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
| 01/13/1999 | EP0671910A4 Glaucoma treatment. |
| 01/13/1999 | EP0627438B1 Methanediphosphonate derivative, process for producing the same, and pharmaceutical use thereof |
| 01/13/1999 | EP0555327B1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
| 01/13/1999 | CN1205010A Isoxazolidine derivatives |
| 01/13/1999 | CN1205009A Pyrazolopyrimidines type compound |
| 01/13/1999 | CN1205006A Substituted tetracyclic tetrahydrofuran derivatives |
| 01/13/1999 | CN1205005A Certain substituted benzylamine derivatives, new class of neuropeptide Y1 specific ligands |
| 01/13/1999 | CN1205004A Esters of 3-hydroxy-piperidinemethanol derivatives |
| 01/13/1999 | CN1204965A Anion exchange resin-containing tablets |
| 01/13/1999 | CN1204964A New combination |
| 01/13/1999 | CN1204963A Medicine for preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (NOS) |
| 01/13/1999 | CN1204962A Synergistic immunosuppressant composition containing 2,2'-Bi-1H-pyrrole compound |
| 01/13/1999 | CN1204961A Eyedrops |
| 01/13/1999 | CN1204960A Novel stable preparation use paracetamol as base and method for preparing same |
| 01/13/1999 | CN1204958A Skin treatment with salicyclic acid esters esters and eka-vitamin A |
| 01/13/1999 | CN1204650A Method for preparing platinum compound |
| 01/13/1999 | CN1204649A Naloxonate and naltrexonate and series product and preparation method |
| 01/13/1999 | CN1204648A Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 01/13/1999 | CN1204515A Chinese medicinal preparation for treatment of toothache and method for preparation thereof |
| 01/13/1999 | CN1204512A Medicine for prevention and cure of chilblain |
| 01/13/1999 | CN1204511A Anticancer medicine and preparation technology thereof |
| 01/13/1999 | CN1204510A Stype using gossypol (and) its derivative as active component and use |
| 01/13/1999 | CN1204509A Pharmaceutical aerosol formulation |
| 01/13/1999 | CN1041633C Novel 2-thiosubstituted carbapenems |
| 01/13/1999 | CN1041632C Process for preparation of 9-(2-hydroxy)-ethoxymethyl-guanine |
| 01/13/1999 | CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor |
| 01/13/1999 | CN1041600C Process for preparing polyisoprene compound having high content for soft capsules |
| 01/13/1999 | CN1041599C Quick-cold oral liquid for child and preparing method thereof |
| 01/12/1999 | US5859295 Canavanine analogs and their use as chemotherapeutic agents |
| 01/12/1999 | US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859256 Chlorination; useful as antibacterial agents and in treating diseases caused by organisms which are resistant to beta-lactam antibiotics |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859246 Treating neuropsychological disorders |
| 01/12/1999 | US5859244 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/12/1999 | US5859240 Reduction of imine group; oxidation; salt formation |
| 01/12/1999 | US5859238 Reacting crude clavulanic acid extract in organic solvent with alkylenediamine to form diammonium salt, isolating, reacting with potassium 2-ethylhexanaote in isopropanol to form potassium clavulanate |